지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2022.7
- 수록면
- 585 - 591 (7page)
이용수
초록· 키워드
오류제보하기
Background: Korean Red Ginseng (KRG) extract has been shown to have beneficial effects in patients with atherosclerosis, suggesting that KRG extract may be effective in preventing subsequent ischemic stroke in patients with severe atherosclerosis.
Methods: This double-blind, placebo-controlled trial randomized patients with severe atherosclerosis in major intracranial arteries or extracranial carotid artery, to ginseng group and placebo group. They were given two 500-mg KRG tablets or identical placebo tablets twice daily for 12 months according to randomization. The primary endpoint was the composite of cerebral ischemic stroke and transient ischemic attack during 12 months after randomization. The secondary endpoints were change in volumetric blood flow of the intracranial vessels and the incidence of newly developed asymptomatic ischemic lesions. Any adverse events were monitored.
Results: Fifty-eight patients were randomized from June 2016 to June 2017, 29 to ginseng and 29 to placebo, and 52 (28 and 24, respectively) completed the study. One patient in the placebo group, but none in the ginseng group, experienced ischemic symptoms (p = 0.46). Changes in volumetric blood flow and the presence of ischemic brain lesions did not differ significantly in the two groups, and none of these patients experienced adverse drug reactions.
Conclusion: Ginseng was well tolerated by patients with severe atherosclerosis, with these patients showing good compliance with ginseng dosing. Ginseng did not show significant effects compared with placebo, although none of the ginseng-treated patients experienced ischemic events. Long-term studies in larger patient populations are required to test the effect of ginseng.
Methods: This double-blind, placebo-controlled trial randomized patients with severe atherosclerosis in major intracranial arteries or extracranial carotid artery, to ginseng group and placebo group. They were given two 500-mg KRG tablets or identical placebo tablets twice daily for 12 months according to randomization. The primary endpoint was the composite of cerebral ischemic stroke and transient ischemic attack during 12 months after randomization. The secondary endpoints were change in volumetric blood flow of the intracranial vessels and the incidence of newly developed asymptomatic ischemic lesions. Any adverse events were monitored.
Results: Fifty-eight patients were randomized from June 2016 to June 2017, 29 to ginseng and 29 to placebo, and 52 (28 and 24, respectively) completed the study. One patient in the placebo group, but none in the ginseng group, experienced ischemic symptoms (p = 0.46). Changes in volumetric blood flow and the presence of ischemic brain lesions did not differ significantly in the two groups, and none of these patients experienced adverse drug reactions.
Conclusion: Ginseng was well tolerated by patients with severe atherosclerosis, with these patients showing good compliance with ginseng dosing. Ginseng did not show significant effects compared with placebo, although none of the ginseng-treated patients experienced ischemic events. Long-term studies in larger patient populations are required to test the effect of ginseng.
목차
ABSTRACT
1. Introduction
2. Materials and methods
3. Results
4. Discussion
5. Conclusion and Recommendation
References
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Effectiveness of perilla oil in the improvement of atherosclerosis and ischemic stroke
한국실험동물학회 학술발표대회 논문집
2017 .02
-
A comprehensive quality analysis of randomized controlled clinical trials of Asian ginseng and American ginseng based on the CONSORT guideline
Journal of Ginseng Research
2022 .01
-
Safety and tolerability of Korean Red Ginseng in healthy adults : a multicenter, double-blind, randomized, placebo-controlled trial
Journal of Ginseng Research
2018 .10
-
Safety and antifatigue effect of Korean Red Ginseng capsule: A randomized, double-blind and placebo-controlled clinical trial
Journal of Ginseng Research
2022 .07
-
Lipids in Ginseng (Panax ginseng) and Their Analysis
Natural Product Sciences
2018 .03
-
고려인삼(Panax ginseng)과 미국삼(Panax quinquefolium)의 승열작용에 대한 비교 고찰
생약학회지(Korean Journal of Pharmacognosy)
2018 .09
-
Functional role of ginseng-derived compounds in cancer
Journal of Ginseng Research
2018 .06
-
Review of cases of patient risk associated with ginseng abuse and misuse
Journal of Ginseng Research
2015 .04
-
Effect of Ginseng on Blood Pressure: A Systematic Review and Meta-Analysis
한국임상약학회지
2016 .01
-
Effect of Korean Red Ginseng in individuals exposed to high stress levels: a 6-week, double-blind, randomized, placebo-controlled trial
Journal of Ginseng Research
2019 .06
-
Characterization of Korean Red Ginseng (Panax ginseng Meyer) : History, preparation method, and chemical composition
Journal of Ginseng Research
2015 .10
-
Red ginseng monograph
Journal of Ginseng Research
2018 .10
-
The beneficial potential of ginseng for menopause
Journal of Ginseng Research
2024 .09
-
The effects of Korean Red Ginseng on stress-related neurotransmitters and gene expression: A randomized, double-blind, placebo-controlled trial
Journal of Ginseng Research
2023 .11
-
In situ analysis of chemical components induced by steaming between fresh ginseng, steamed ginseng, and red ginseng
Journal of Ginseng Research
2017 .07
-
고려인삼의 혈압에 미치는 영향에 대한 이해
생약학회지(Korean Journal of Pharmacognosy)
2017 .06
-
한말(1896-1897) 왕실의 홍삼 정책과 수출 연구
연세의사학
2024 .06
-
Implications of red Panax ginseng in oxidative stress associated chronic diseases
Journal of Ginseng Research
2017 .04
-
경증의 간 기능 이상 소견을 보이는 건강한 성인에 대한 인삼종자오일의 유효성 및 안전성 연구 : 무작위배정, 이중눈가림, 위약대조 연구
대한한의학회지
2018 .06
-
Statin and the Risk of Ischemic Stroke or Transient Ischemic Attack in Head and Neck Cancer Patients with Radiotherapy
대한뇌졸중학회지
2018 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2023-524-000241566